Why were some proceeds from the Colgate-Palmolive (CL) CFO’s share sale delivered to the company?

A portion of the sale proceeds was delivered to Colgate-Palmolive to pay the exercise price of the stock options and cover related tax withholding. This is a common structure when executives exercise options and simultaneously sell shares to fund the costs and associated taxes.

Colgate-Palmolive (NYSE: CL) CFO sells 97,843 shares after option exercise

Filing Impact

(Very High)

Filing Sentiment

(Very Negative)

Form Type

Rhea-AI Filing Summary

Colgate-Palmolive’s Chief Financial Officer, Stanley J. Sutula III, exercised stock options and sold shares in a planned transaction. On February 4, 2026, he exercised 97,843 stock options at an exercise price of $81.78 per share under the company’s incentive compensation plan.

That same day, he sold 97,843 shares of common stock at a weighted average price of $94.2662 per share, with a portion of the proceeds delivered to Colgate-Palmolive to cover the option exercise price and related tax withholding. After these transactions, he directly owned 55,310 common shares and indirectly held 328 shares through the issuer’s 401(k) plan trustee.

Insider Trade Summary

Net Seller: 97,843 shares ($9,223,288)

Net Sell 4 txns

Insider SUTULA STANLEY J III

Role Chief Financial Officer

Sold 97,843 shs ($9.22M)

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	97,843	$0.00	--
Exercise	Common Stock	97,843	$81.78	$8.00M
Sale	Common Stock	97,843	$94.2662	$9.22M
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 0 shares (Direct); Common Stock — 153,153 shares (Direct); Common Stock — 328 shares (Indirect, By Issuer's 401(k) Plan Trustee)

Footnotes (1)

Exercise of stock options awarded under the issuer's incentive compensation plan. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $93.97 to $94.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. Option became exercisable in one-third increments beginning on the first anniversary of the November 9, 2020 grant date.

Form 4 Insider Transactions: What Each Field Means →

02/06/2026 - 04:06 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SUTULA STANLEY J III

(Last)

(First)

(Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK

10022

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/04/2026		M⁽¹⁾		97,843	A	$81.78	153,153	D
Common Stock	02/04/2026		S⁽²⁾		97,843	D	$94.2662⁽³⁾	55,310	D
Common Stock								328	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$81.78	02/04/2026		M⁽¹⁾			97,843	⁽⁴⁾	11/09/2028	Common Stock	97,843	$0.0000	0.0000	D

Explanation of Responses:

1. Exercise of stock options awarded under the issuer's incentive compensation plan.

2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.

3. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $93.97 to $94.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. Option became exercisable in one-third increments beginning on the first anniversary of the November 9, 2020 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Colgate-Palmolive (CL) report for its CFO?

Colgate-Palmolive reported that CFO Stanley J. Sutula III exercised 97,843 stock options and sold 97,843 common shares on February 4, 2026. These transactions were made under the company’s incentive compensation plan, with part of the sale proceeds used for exercise costs and tax withholding.

How many Colgate-Palmolive (CL) shares did the CFO sell and at what price?

The CFO sold 97,843 Colgate-Palmolive common shares at a weighted average price of $94.2662 per share. The filing notes these shares were sold in multiple trades between $93.97 and $94.53, and detailed price information is available upon request from the reporting person.

What stock options did the Colgate-Palmolive (CL) CFO exercise?

He exercised 97,843 stock options with an exercise price of $81.78 per share on February 4, 2026. These options were granted under Colgate-Palmolive’s incentive compensation plan and became exercisable in one-third increments starting on the first anniversary of the November 9, 2020 grant date.

How many Colgate-Palmolive (CL) shares does the CFO own after this Form 4 filing?

Following the reported transactions, the CFO directly owned 55,310 Colgate-Palmolive common shares. He also indirectly held 328 additional shares through the issuer’s 401(k) plan trustee, according to the beneficial ownership information disclosed in the filing.

What does the weighted average price disclosure mean in this Colgate-Palmolive (CL) Form 4?

The weighted average price of $94.2662 means the 97,843 shares were sold in multiple trades between $93.97 and $94.53. The CFO has committed to provide, upon request, the number of shares sold at each specific price within that range to interested parties.